News Release

LOUISVILLE, Ky. and INDIANAPOLIS, Aug. 29, 2013 /PRNewswire/ -- Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, and Eli Lilly and Company (NYSE: LLY), a leading, innovation-driven corporation, today announced a joint research collaboration aimed at improving the health care of their members and patients.

Under the partnership, the companies will utilize their expertise and resources to identify and analyze data and information with a focus on improving health care quality and outcomes. The partnership reflects a shared commitment by both companies to address the challenges of improving quality of care and reducing treatment costs in today's complex and changing health care environment.

"Pairing Humana's clinical expertise and rich, de-identified patient data with Lilly's history and experience across many disease states allows us to maximize the potential benefits for patient care and savings," said William Fleming, Pharm.D., President of Humana Pharmacy Solutions. "By leveraging our collective capabilities, we can work to address the critical health care needs facing our country." 

Under the terms of the multi-year agreement, the companies will conduct a range of studies related to various disease states. Study methodologies include: impact of interventions on outcomes, adherence programs, disease management and pharmacoeconomics.

The initial project is aimed at investigating patient characteristics associated with increased health care costs in people with type 2 diabetes. This retrospective analysis utilizes de-identified medical, pharmacy and laboratory claims data, in addition to research algorithms focused on exploring patient attitudes and behaviors. Future studies may use this information to identify modifiable characteristics that can be targeted with behavioral and other therapeutic interventions.

"We are pleased to partner with Humana on research that will help benefit patients facing a variety of diseases, including diabetes," said Dara Schuster, M.D., Medical Fellow, Lilly Diabetes. "Working together, we hope to provide patients with insights and guidance that will help them tailor their care to best match their individual needs."

Comprehensive Health Insights (CHI), a wholly owned subsidiary of Humana, will serve as the research engine in the collaboration.  Since 2008 CHI has successfully partnered with a wide range of industry partners to perform health economics and outcomes research using Humana's data assets.

About Humana
Humana Inc., headquartered in Louisville, Ky., is a leading health-care company that offers a wide range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. By leveraging the strengths of its core businesses, Humana believes it can better explore opportunities for existing and emerging adjacencies in health care that can further enhance wellness opportunities for the millions of people across the nation with whom the company has relationships.

More information regarding Humana is available to investors via the Investor Relations page of the company's web site at www.humana.com, including copies of:

• Annual reports to stockholders
• Securities and Exchange Commission filings
• Most recent investor conference presentations
• Quarterly earnings news releases
• Replays of most recent earnings release conference calls
• Calendar of events (including upcoming earnings conference call dates and times, as well as planned interaction with research analysts and institutional investors)
• Corporate Governance information

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers — through medicines and information — for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

C-LLY

FOR MORE INFORMATION, CONTACT:

Alex Kepnes
Humana Corporate Communications 
502-580-2990
akepnes@humana.com  

Kelley Murphy
Eli Lilly and Company
317-701-4007
murphy_kelley@lilly.com   

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )

(Logo: http://photos.prnewswire.com/prnh/20130829/DE70165LOGO )

SOURCE Eli Lilly and Company; Humana Inc.